On February 2, 2021, Healthcare Integrated Technologies, Inc. (the “Company”) completed the sale of a Promissory Note in the principal amount of $360,000 (the “Note”) to AJB Capital Investments, LLC (the “Purchaser”) for a purchase price of $320,400, in a private transaction exempt from registration under the Securities Act of 1933, as amended, in reliance on exemptions provided by Section 4(a)(2) and Rule 506(b) of Regulation D promulgated thereunder. The Purchaser was an accredited or otherwise sophisticated investor who had access to business and financial information on the Company. We paid $31,256 in finder’s fees in connection with the sale of the Note. After payment of the finder’s fees and closing cost, the sale of the Note resulted in $276,644 in net proceeds to the Company. The net proceeds from the sale will be used for working capital. The Note matures on August 2, 2021 (the “Maturity Date”), bears interest at a rate of 10% per annum, and, following an event of default only, is convertible into shares of the Company’s common stock at a conversion price equal to the lesser of 90% of the lowest trading price during (i) the 20 trading day period preceding the issuance date of the note, or (ii) the 20 trading day period preceding date of conversion of the Note. The Note is also subject to covenants, events of defaults, penalties, default interest and other terms and conditions customary in transactions of this nature.